Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShawbrook 99 Regulatory News (PH56)

Share Price Information for Shawbrook 99 (PH56)

Share Price is delayed by 15 minutes
Get Live Data
89.875    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
PH56 Live PriceLast checked at - London Stock Exchange

Intraday Shawbrook 99 Share Chart

Shawbrook Group plc Pre-Stabilisation Notice

30 Oct 2025 07:00

RNS Number : 4014F
Barclays Bank PLC
30 October 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE UNLAWFUL. 

30 October 2025

Shawbrook Group plcPre-Stabilisation Notice

Barclays Capital Securities Limited (Contact: Ben Newmark; Telephone: +44 20 3134 8574) hereby gives notice that the Stabilising Manager named below and its affiliates may stabilise the offer of the following securities in accordance with the relevant provisions of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of retained EU law as defined in the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as it forms part of retained EU law as defined in the European Union (Withdrawal) Act 2018).

 The securities

Issuer

Shawbrook Group plc

Securities

Ordinary Shares of £0.005 pence each

ISIN

GB00BV9DPV21

Offering Size

94,007,050 Ordinary Shares (excluding the over-allotment option)

Description

Initial Public Offering of Ordinary Shares

Offer price

370 pence per Ordinary Share

Stabilisation:

Stabilising Manager

Barclays Capital Securities Limited, 1 Churchill Place, London, E14 5HP, United Kingdom

Stabilisation period expected to start on

30 October 2025 (approximately 08:00am (London time))

Stabilisation period expected to end no later than

28 November 2025 (close of business)

Stabilisation trading venue

London Stock Exchange

Over-allotment Option:

Terms of Over-allotment Option

Marlin Bidco Limited has granted the Stabilising Manager, the option to acquire additional Ordinary Shares at the Offer Price. The Over-allotment Option may be exercised in full or in part at any time during the stabilisation period.

Maximum size of Over-allotment Option

The Stabilising Manager may over-allot the securities to the extent permitted in accordance with the applicable law, up to the maximum size of 14,101,057 Ordinary Shares.

Duration of Over-allotment Option

The Over-allotment Option may be exercised in full or in part at any time during the stabilisation period. 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

In the United Kingdom, this announcement is being distributed only to, and is directed only at, persons who: (A) (i) are "investment professionals" specified in Article 19(5) of the Financial Services and Markets Act (Financial Promotion) Order 2005 (the "Order") and/or (ii) fall within Article 49(2)(a) to (d) of the Order (and only where the conditions contained in those Articles have been, or will at the relevant time be, satisfied); and (B) are "qualified investors" within the meaning of Article 2 of the Prospectus Regulation (Regulation (EU) 2017/1129) as it forms part of retained EU law as defined in the EU (Withdrawal) Act 2018 (all such persons together being referred to as "Relevant Persons").

In any member state of the European Economic Area ("EEA") (each, a "Relevant Member State"), this announcement and any offer if made subsequently is, and will be, directed only at persons who are "qualified investors" ("Qualified Investors") within the meaning of the Prospectus Regulation (Regulation (EU) 2017/1129).

This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not Relevant Persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to: (i) in the United Kingdom, Relevant Persons; and (ii) in any member state of the EEA, Qualified Investors, and will be engaged in only with such persons.

This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities in the United States or any other jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933 as amended (the "Securities Act") and may not be offered or sold in the United States except to "qualified institutional buyers" as defined in, and in reliance on, Rule 144A under the Securities Act or another exemption from, or transaction not subject to, the registration requirements of the Securities Act. All offers and sales of securities outside of the United States will be made in reliance on, and in compliance with, Regulation S under the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAUKAWRVWURUAA
Date   Source Headline
30th Oct 20257:00 amRNSShawbrook Group plc Pre-Stabilisation Notice
21st Oct 202510:43 amRNSCommencement of Retail Offer
21st Oct 202510:38 amRNSPublication of Price Range Prospectus
21st Oct 20258:17 amRNSAnnouncement of Price Range
13th Oct 20257:00 amRNSConfirmation of Intention to Float
6th Oct 202510:57 amRNSFCA Approves Registration Document
6th Oct 20257:00 amRNSExpected Intention to Float
30th Sep 20254:31 pmRNSCompletion of ThinCats Group Limited Acquisition
2nd Sep 20257:00 amRNSAcquisition of ThinCats Group Limited
7th Aug 20257:00 amRNSInterim Report for the period ended 30 June 2025
9th Jun 20259:00 amRNSNotice of Redemption to Noteholders
3rd Jun 202510:24 amRNSDirector / PDMR Shareholding
3rd Jun 202510:17 amRNSTier 2 Issuance Pricing Supplement
2nd Jun 202510:23 amRNSDirector / PDMR Shareholding
2nd Jun 202510:20 amRNSTender Results: Fixed Rate Subordinated Notes 2030
29th May 20252:39 pmRNSResidential Mortgage-Backed Securities May 2025
22nd May 20254:28 pmRNSTender Offer: Fixed Rate Subordinated Notes 2030
15th May 20257:00 amRNSShawbrook Q1 2025 Trading Update
27th Mar 20257:00 amRNSShawbrook Full Year 2024 Results
8th Nov 20247:00 amRNSShawbrook Q3 2024 Trading Update
30th Oct 20245:19 pmRNSResidential Mortgage-Backed Securities October 24
30th Sep 20245:00 pmRNSCompletion of JBR Auto Holdings Ltd Acquisition
13th Aug 20244:58 pmRNSRedemption of outstanding Tier 2 Notes due 2029
8th Aug 20247:00 amRNSInterim Report for the period ended 30 June 2024
17th Jun 20247:00 amRNSShawbrook to acquire JBR Auto Holdings Ltd
15th May 20247:00 amRNSShawbrook Q1 2024 Trading Update
28th Mar 20247:00 amRNSShawbrook Full Year 2023 Results
21st Nov 20235:00 pmRNSResidential Mortgage Backed Securities Nov 2023
9th Nov 20237:00 amRNSQ3 2023 Trading Update
4th Oct 202311:18 amRNSDirector/PDMR Shareholding
4th Oct 202311:13 amRNSPublication of Suppl. Prospectus
10th Aug 20237:00 amRNSInterim Report for the period ended 30 June 2023
11th Jul 20235:00 pmRNSShawbrook establishment of EMTN Programme
29th Jun 20235:00 pmRNSResidential Mortgage Backed Securities - June 23
1st Jun 20237:00 amRNSCompletion of Bluestone Mortgages Ltd Acquisition
17th May 20237:00 amRNSQ1 2023 Trading Update
30th Mar 20237:00 amRNS2022 Annual Report and Accounts
20th Mar 20237:00 amRNSAcquisition of Bluestone Mortgages Limited (BML)
13th Dec 20223:24 pmRNSResidential Mortgage-Backed Securities (RMBS)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.